Stockreport

Milestone Pharmaceuticals: Interesting, But Not Well-Differentiated From Generic Competition [Seeking Alpha]

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report
PDF Milestone Pharmaceuticals: Interesting, But Not Well-Differentiated From Generic Competition Summary MIST is a recent IPO specialising in CV drugs. Its lead drug Etripam [Read more]